When most investors think of "under the radar" stocks, they think of small caps. But in this short video, Hilary Kramer discusses three health care stocks that are not that well known, but that she thinks will do very well for investors. Two of them have market caps in the billions.
Here's a stock that is the largest drugstore operator in China, but still has huge growth ahead of it. The company just got costs under control, and has a new CEO. Plus, the stock is traded on the NYSE and sports a hefty dividend. Yet few know about it.
Looking for companies that are growing fast but still ignored by Wall Street? Hilary Kramer talks about two stocks here with great upside potential. One of them, she says, could even be a ten-bagger.
Hilary Kramer recently recommended shares of Jazz Pharmaceuticals, which surged 16% on Wednesday before closing up just 3%. The reason: The FDA approved Xyrem, a drug used for narcolepsy, for fibromyalgia. What could be next? Besides Jazz, Kramer also recommends two biotech medical equipment companies.